Welcome to your Pharmacology Foundations & Pharmacokinetics Arena
1.
A patient develops prolonged paralysis after receiving succinylcholine during a procedure. The reaction is traced to an inherited abnormality of plasma pseudocholinesterase. Which pharmacological concept is best illustrated?
2.
A pharmaceutical researcher studies multiple genetic variations across the genome to predict differences in response to several drug classes and to support individualized drug selection. Which field is most directly involved?
3.
A patient stabilized on an oral anticoagulant begins treatment with rifampicin. Several days later, the anticoagulant effect decreases despite unchanged dosing. Which pharmacokinetic mechanism best explains this finding?
4.
A patient requires rapid achievement of a target plasma concentration of 10 mg/L. The prescribed drug has a volume of distribution of 40 L and oral bioavailability of 0.5. What loading dose should be administered?
5.
A pregnant woman receives a lipid-soluble medication. The drug is later detected in fetal circulation. Which property most strongly facilitates this transfer?
6.
Two tablet formulations of the same drug are administered under comparable conditions. Their plasma concentration-time curves show closely comparable rates and extents of systemic availability. Which relationship between the two products is best demonstrated?
7.
A drug is metabolized by an enzyme located in plasma rather than in hepatic microsomes. Which classification best describes this enzyme?
8.
A highly ionized drug crosses a lipid membrane after temporarily combining with an oppositely charged endogenous ion to form a neutral, more lipid-soluble complex. Which transport mechanism explains this movement?
9.
A patient receives a drug that undergoes glucuronidation in the liver. Which description best characterizes this reaction?
10.
An oral drug undergoes extensive hepatic metabolism during its initial passage from the gastrointestinal tract to the systemic circulation. A different route is being considered to improve the amount of unchanged drug reaching systemic blood. Which route would most directly bypass gastrointestinal absorption and initial portal passage while still permitting sustained administration?
11.
Two patients receive the same standard dose of a drug, but one develops an unusually strong response because of an inherited variation affecting drug metabolism. The study of this individual inherited variation is primarily included in:
12.
A highly polar antimicrobial has adequate plasma levels but fails to achieve an effective concentration within brain tissue. Which structural feature is primarily responsible for this restricted distribution?
13.
A dermatologist prescribes two preparations applied to the skin. One corticosteroid cream is intended to act mainly at the site of application, whereas another preparation is designed to provide prolonged systemic delivery through intact skin. The second preparation is best classified as:
14.
Two patients receive the same dose of a drug metabolized by a genetically variable enzyme. One patient develops a very high plasma concentration and toxicity, while the other has a lower concentration. Which concept best explains this difference?
15.
A small quantity of an antigen preparation is injected into the superficial layer of the skin to observe a localized response. Which feature best distinguishes this administration from a routine subcutaneous injection?
16.
A laboratory investigates drug metabolism in hepatocytes and isolates enzymes associated with fragments of smooth endoplasmic reticulum. Which enzyme system is most likely being studied?
17.
A researcher compares systemic exposure after equal doses of the same drug given orally and intravenously. The oral concentration-time curve has a substantially smaller area under the curve despite adequate gastrointestinal absorption. Which process most plausibly accounts for the reduced oral exposure?
18.
A 64-year-old man with chronic liver disease is receiving a highly albumin-bound drug. His serum albumin is markedly reduced, and he develops exaggerated pharmacological effects despite receiving the standard dose. Which change best explains this response?
19.
A severely dehydrated patient with poor peripheral perfusion requires a medication whose absorption should not depend on blood flow through muscle or subcutaneous tissue. Which route provides the most predictable systemic delivery?
20.
A prodrug is administered to a patient and has little pharmacological activity until it is metabolized in the liver. Which possible outcome of biotransformation is illustrated?
21.
A 70-kg patient receives 700 mg of a drug intravenously. Soon afterward, its plasma concentration is measured as 14 mg/L. Which value best represents its apparent volume of distribution?
22.
Two drugs are administered intravenously in equal doses. Drug X has a volume of distribution of 5 L, while Drug Y has a volume of distribution of 150 L. Which interpretation is most appropriate?
23.
A patient receives an intramuscular drug during profound circulatory shock. The expected clinical effect is delayed compared with administration of the same drug after restoration of circulation. Which factor most directly explains this difference?
24.
Two oral preparations containing the same active drug in the same dosage form and strength satisfy the required pharmaceutical standards. However, one produces a substantially different plasma concentration-time profile. Which statement is most accurate?
25.
A lipid-soluble intravenous anesthetic produces unconsciousness within seconds. The patient awakens shortly afterward despite minimal metabolism of the drug during this period. Which pharmacokinetic event most directly explains recovery?
26.
A drug molecule moves across a membrane through a specific carrier. Transport proceeds down the concentration gradient, requires no metabolic energy, and reaches a maximum rate when all carriers become occupied. Which mechanism is most consistent with these findings?
27.
A drug is converted by hepatic CYP450 enzymes into a metabolite through oxidation before undergoing conjugation. The oxidation step belongs to which metabolic category?
28.
A drug with a long half-life is started for a condition in which therapeutic effect is required promptly. The physician administers a large initial dose followed by smaller repeated doses. What is the main purpose of the first dose?
29.
A drug is metabolized by a particular enzyme into a reactive intermediate. This intermediate then binds strongly to the same enzyme and inactivates it, so recovery requires restoration of functional enzyme activity. Which mechanism is being described?
30.
A large therapeutic molecule cannot readily diffuse through the lipid bilayer. The cell membrane surrounds the molecule and incorporates it into an intracellular vesicle. Which process has occurred?
31.
A second drug is transported by a membrane carrier and can move from a region of lower concentration to a region of higher concentration. Its transport decreases when cellular energy production is inhibited. Which mechanism is responsible?
32.
A drug remains largely confined to the bloodstream because it is strongly bound to plasma proteins and poorly enters tissues. Which pharmacokinetic pattern is most likely?
33.
A drug is conjugated in the liver and excreted into bile. In the intestine, the conjugated compound is converted back to an absorbable form and returns through the portal circulation. Interruption of this process would most likely produce which pharmacokinetic consequence?
34.
A 54-year-old man develops acute ischemic chest discomfort. A rapidly acting drug is selected that should enter the systemic circulation quickly while minimizing initial hepatic metabolism. Which route best fulfills these requirements?
35.
Two formulations contain the same drug and dose. Formulation X dissolves rapidly, while formulation Y dissolves slowly. After oral administration, X produces an earlier and higher plasma peak although both eventually provide substantial systemic exposure. Which factor most directly accounts for the difference?
36.
A patient has markedly accelerated intestinal transit due to severe diarrhea. An orally administered medicine produces less effect than expected despite normal liver function. Which change most directly explains the reduced absorption?
37.
A natural plant preparation produces a therapeutic effect because it contains a chemically identifiable constituent that can be isolated and standardized. Which term best describes this constituent?
38.
A patient receives a lipid-soluble drug that undergoes hepatic metabolism. The metabolic product is more polar and is more readily eliminated in urine. Which statement best explains the purpose of this transformation?
39.
A hospital committee is preparing a limited list of medicines approved for routine prescribing within the institution. The document includes selected drugs along with information to guide their rational use. Which term best describes this document?
40.
A patient receiving a drug metabolized by hepatic CYP enzymes is prescribed erythromycin. Soon afterward, the patient develops concentration-related adverse effects from the first drug. Which change is most likely responsible?
